Paper2016229
Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.
Aman MG and 4 others. J Am Acad Child Adolesc Psychiatry, 1991. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Papers, record 2016229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2016229
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Attention Deficit Disorder with Hyperactivity | Major topic |
| Child Behavior Disorders | Major topic |
| Intellectual Disability | Major topic |
| Methylphenidate | Major topic |
| Thioridazine | Major topic |
| Adolescent | |
| Attention | |
| Child | |
| Child, Preschool | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Parents | |
| Placebos | |
| Teaching |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35633446 | Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study. | J Autism Dev Disord | 2023 | https://conductscience.org/library/papers/35633446 | PubMed |
| 32644833 | Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. | J Child Adolesc Psychopharmacol | 2020 | https://conductscience.org/library/papers/32644833 | PubMed |
| 29865900 | Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update. | Can J Psychiatry | 2018 | https://conductscience.org/library/papers/29865900 | PubMed |
| 27520752 | Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective. | CNS Drugs | 1997 | https://conductscience.org/library/papers/27520752 | PubMed |
| 25886657 | Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder. | Can J Psychiatry | 2015 | https://conductscience.org/library/papers/25886657 | PubMed |
| 23133462 | Efficacy of Methylphenidate in ADHD Children across the Normal and the Gifted Intellectual Spectrum. | J Can Acad Child Adolesc Psychiatry | 2012 | https://conductscience.org/library/papers/23133462 | PubMed |
| 22899942 | Clinic-based retrospective analysis of psychopharmacology for behavior in fragile x syndrome. | Int J Pediatr | 2012 | https://conductscience.org/library/papers/22899942 | PubMed |
| 18392193 | Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. | J Can Acad Child Adolesc Psychiatry | 2006 | https://conductscience.org/library/papers/18392193 | PubMed |
| 15584771 | Pharmacotherapy of pervasive developmental disorders in children and adolescents. | CNS Drugs | 2004 | https://conductscience.org/library/papers/15584771 | PubMed |
| 11140783 | Medication treatment in subjects with autistic spectrum disorders. | Eur Child Adolesc Psychiatry | 2000 | https://conductscience.org/library/papers/11140783 | PubMed |
| 11140776 | Typical neuroleptics in child and adolescent psychiatry. | Eur Child Adolesc Psychiatry | 2000 | https://conductscience.org/library/papers/11140776 | PubMed |
| 10937459 | Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy. | Paediatr Drugs | 2000 | https://conductscience.org/library/papers/10937459 | PubMed |
| 9711446 | Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder. | Drugs | 1998 | https://conductscience.org/library/papers/9711446 | PubMed |
| 9304445 | Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD. | J Abnorm Child Psychol | 1997 | https://conductscience.org/library/papers/9304445 | PubMed |
| 8926223 | Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation. | J Appl Behav Anal | 1996 | https://conductscience.org/library/papers/8926223 | PubMed |
| 8347290 | Risks and benefits of drugs used in the management of the hyperactive child. | Drug Saf | 1993 | https://conductscience.org/library/papers/8347290 | PubMed |
| 1361998 | Management of psychopharmacologic agents in children and adolescents. | Psychiatr Q | 1992 | https://conductscience.org/library/papers/1361998 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2016229
GET https://conductscience.org/api/papers/v1/2016229/authors